Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein
- PMID: 11495914
- DOI: 10.1074/jbc.M105365200
Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein
Abstract
The microtubule-associated protein tau is a family of six isoforms that becomes abnormally hyperphosphorylated and accumulates in neurons undergoing neurodegeneration in the brains of patients with Alzheimer disease (AD). We investigated the isoform-specific interaction of normal tau with AD hyperphosphorylated tau (AD P-tau). We found that the binding of AD P-tau to normal human recombinant tau was tau4L > tau4S > tau4 and tau3L > tau3S > tau3, and that its binding to tau4L was greater than to tau3L. AD P-tau also inhibited the assembly of microtubules promoted by each tau isoform and caused disassembly when added to preassembled microtubules. This inhibition and depolymerization of microtubules by the AD P-tau corresponded directly to the degree of its interaction with the different tau isoforms. In vitro hyperphosphorylation of recombinant tau (P-tau) conferred AD P-tau-like characteristics. Like AD P-tau, P-tau interacted with and sequestered normal tau and inhibited microtubule assembly. These studies suggest that the AD P-tau interacts preferentially with the tau isoforms that have the amino-terminal inserts and four microtubule binding domain repeats and that hyperphosphorylation of tau appears to be sufficient to acquire AD P-tau characteristics. Thus, lack of amino-terminal inserts and extra microtubule binding domain repeat in fetal human brain might be protective from Alzheimer's neurofibrillary degeneration.
Similar articles
-
Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level.FEBS Lett. 2006 Oct 30;580(25):5925-33. doi: 10.1016/j.febslet.2006.09.060. Epub 2006 Oct 5. FEBS Lett. 2006. PMID: 17045592 Free PMC article.
-
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.Eur J Neurosci. 2007 Jan;25(1):59-68. doi: 10.1111/j.1460-9568.2006.05226.x. Eur J Neurosci. 2007. PMID: 17241267 Free PMC article.
-
Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau.Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):298-303. doi: 10.1073/pnas.94.1.298. Proc Natl Acad Sci U S A. 1997. PMID: 8990203 Free PMC article.
-
Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.J Neural Transm Suppl. 1998;53:169-80. doi: 10.1007/978-3-7091-6467-9_15. J Neural Transm Suppl. 1998. PMID: 9700655 Review.
-
Tau in Alzheimer disease and related tauopathies.Curr Alzheimer Res. 2010 Dec;7(8):656-64. doi: 10.2174/156720510793611592. Curr Alzheimer Res. 2010. PMID: 20678074 Free PMC article. Review.
Cited by
-
Mechanisms of tau-induced neurodegeneration.Acta Neuropathol. 2009 Jul;118(1):53-69. doi: 10.1007/s00401-009-0486-3. Epub 2009 Jan 30. Acta Neuropathol. 2009. PMID: 19184068 Free PMC article. Review.
-
Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.Brain. 2009 Jul;132(Pt 7):1820-32. doi: 10.1093/brain/awp099. Epub 2009 May 18. Brain. 2009. PMID: 19451179 Free PMC article.
-
Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.Eur J Neurosci. 2011 May;33(9):1598-610. doi: 10.1111/j.1460-9568.2011.07660.x. Epub 2011 Apr 1. Eur J Neurosci. 2011. PMID: 21453448 Free PMC article.
-
Tau Oligomers as Pathogenic Seeds: Preparation, Characterization, and Propagation In Vitro and In Vivo.Methods Mol Biol. 2024;2754:147-183. doi: 10.1007/978-1-0716-3629-9_9. Methods Mol Biol. 2024. PMID: 38512666
-
Retromer dysfunction at the nexus of tauopathies.Cell Death Differ. 2021 Mar;28(3):884-899. doi: 10.1038/s41418-020-00727-2. Epub 2021 Jan 20. Cell Death Differ. 2021. PMID: 33473181 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous